![](https://www.marketscreener.com/images/twitter_MS_fdnoir.png)
US FDA approves Bristol Myers' colorectal cancer therapy
June 21 (Reuters) - The U.S. Food and Drug Administration has approved Bristol Myers Squibb's combination therapy for treating colorectal cancer patients with a specific gene mutation, the health regulator's website showed on Friday. (Reporting by …